Screener
BridgeBio Pharma BBIO Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: BridgeBio Pharma’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001743881-26-000027
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other expense, net | (48,812) | (47,380) | (109,411) | (112,616) |
| Loss before income taxes | (155,891) | (181,658) | (322,446) | (351,266) |
| Provision for income taxes | — | 2,100 | — | 2,100 |
| Net loss | (155,891) | (183,758) | (322,446) | (353,366) |
| Net loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests | 3,675 | 1,855 | 6,187 | 4,041 |
| Net loss attributable to common stockholders of BridgeBio | $(152,216) | $(181,903) | $(316,259) | $(349,325) |
| Net loss per share attributable to common stockholders of BridgeBio, basic and diluted | $(0.78) | $(0.95) | $(1.62) | $(1.84) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders of BridgeBio, basic and diluted | 195,785,884 | 190,517,215 | 195,290,642 | 190,332,261 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's net income?
- BridgeBio Pharma (BBIO) reported net income of -$155.89M in Q2 2026.
- How has BridgeBio Pharma's net income changed year-over-year?
- BridgeBio Pharma's net income increased by 15.2% year-over-year, from -$183.76M to -$155.89M.
- What is the long-term trend for BridgeBio Pharma's net income?
- Over 4 years (2021 to 2025), BridgeBio Pharma's net income has grown at a 5.7% compound annual growth rate (CAGR), from -$586.45M to -$732.94M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about BridgeBio Pharma's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude